Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors

3 Aug 2023

Abstract excerpt

INTRODUCTION: Testicular germ cell tumors (TGCTs) are a paradigm for the use of serum tumor markers in clinical management. However, conventional markers such as alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH) have quite limited sensitivities and specificities. Within the last decade, the microRNA-371a-3p (miR371) emerged as a possible new biomarker with promising...

Topics

Join the communities discussing this publication.

Gestational Trophoblastic Disease Studies
Glioma Diagnosis and Treatment
Testicular diseases and treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37568759
DOI: 10.3390/cancers15153944

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell TumorsPMID 37568759Read ↗

Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell TumorsSemantic proximity Read ↗

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell TumoursSemantic proximity Read ↗

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell CancerSemantic proximity Read ↗

Germ cell tumour subtypes display differential expression of microRNA371a-3pSemantic proximity Read ↗

Improving outcomes in germ cell cancers using miRNASemantic proximity Read ↗

Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?Semantic proximity Read ↗

Evaluation of Circulating miRNA Biomarkers of Testicular Germ Cell Tumors during Therapy and Follow-up―A Copenhagen ExperienceSemantic proximity Read ↗

The Role of miRNA in Testicular Cancer: Current Insights and Future PerspectivesSemantic proximity Read ↗

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumoursSemantic proximity Read ↗

Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory SettingSemantic proximity Read ↗

Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell TumoursSemantic proximity Read ↗

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor DiagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.